Two suspected cases tested positive for Lassa fever. On February 25, 2022, case-patient one, a 5-year-old male, developed symptoms: of fever, abdominal pain, and diarrhea; was admitted to a hospital on March 01, 2022; and treated for malaria using antimalaria drugs and antibiotics. On March 03, 2022, Lassa fever was suspected, the specimen was collected and tested positive for Lassa fever by polymerase chain reaction test, however, the patient died on the same day of confirmation.

On February 25, 2022, case patient two, an 8-year-old girl, developed symptoms of skin rashes and fever; was treated with traditional herbs at home. On March 01, 2022, symptoms continued, and she was admitted to a hospital, and treated with antimalarial drugs. Two days after admission, Lassa fever was suspected; a specimen was collected; and tested positive for Lassa fever four days after admission. The patient died on the same day of laboratory confirmation. Both patients lived in the same household with no travel history to any Lassa fever endemic area. We observed poor environmental sanitation around the homes of the patients.  No rodents were found. No additional cases were discovered, and no contact developed symptoms. 


